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Abstract Since the discovery of the new members of the UCP
(uncoupling protein) family, UCP2 and UCP3, very few studies
have dealt with the regulation of their expression. Bearing this in
mind, administration of a single intravenous injection of TNF-K
(100 Wg/kg body weight) to rats resulted in a significant increase
in UCP2 (242%) and UCP3 (113%) gene expression in skeletal
muscle. The results suggest a possible role for UCP2 and UCP3
in the increase of energy expenditure associated with cytokine
treatment.
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1. Introduction
Until very recently, the UCP1 protein ^ present only in
brown adipose tissue ^ was considered to be the only mito-
chondrial protein carrier that stimulated heat production by
dissipating the proton gradient generated during respiration
across the inner mitochondrial membrane and therefore un-
coupling respiration from ATP synthesis. Recently, two new
proteins sharing the same function, UCP2 and UCP3, have
been described. While UCP2 is expressed ubiquitously [1,2],
UCP3 is expressed abundantly and speci¢cally in skeletal
muscle in humans [3^6] and also in brown adipose tissue of
rodents [7,3,4]. Concerning the regulation of their expression,
UCP2 mRNA levels are upregulated in white adipose tissue
and skeletal muscle in obesity-resistant mice but not in an
obesity-prone strain [8], thereby suggesting a possible role as
a defence mechanism against high-fat diet-induced obesity.
Fasting increases UCP2 mRNA in skeletal muscle [9] while
it does not seem to a¡ect the expression of the gene in brown
adipose tissue. In skeletal muscle UCP3 gene expression is
also modulated by food intake: its expression is increased
by fasting [10].
It has been known for a long time that cytokines, tumor
necrosis factor K (TNF-K) in particular, are involved in wast-
ing during pathological states such as cancer or infection due
to their metabolic e¡ects which result in an increased energy
expenditure in the host [11]. However, the molecular mecha-
nisms involved in the increased energetic ine⁄ciency and heat
production are still under discussion. In skeletal muscle, the
cytokine has been shown to have important e¡ects in promot-
ing increased protein turnover and thus contributing to ener-
getic ine⁄ciency [12]. Concerning heat production, it was
demonstrated that, in the young rat, a single intravenous
TNF-K injection increased brown adipose tissue thermogene-
sis, measured as mitochondrial GDP binding [13] ; a similar
e¡ect was observed when the cytokine was intracerebroven-
tricularly injected [14]. Very recently, Faggioni et al. [15] have
reported that UCP2 gene expression is induced by lipopoly-
saccharides (LPS) in several cell types, and therefore have
suggested that it could represent a mechanism for the in-
creased thermogenesis during infection.
Bearing all this in mind, and taking into account that skel-
etal muscle accounts for over 40% of total body weight in
rodents, the aim of the present investigation was to see if an
acute TNF-K administration resulted in the induction of the
UCP2 or UCP3 genes in this tissue.
2. Materials and methods
2.1. Animals
Male Wistar rats (Interfauna, Barcelona, Spain) weighing about 200
g were used. The animals were maintained on a regular light-dark
cycle (light on from 08.00 to 20.00 h) at an ambient temperature of
22 þ 1‡C and had free access to food and water. The diet they were
allowed to eat consisted of 54% carbohydrate, 17% protein and 5% fat
(the residue was non-digestible material; Panlab, Barcelona, Spain).
The animals were anesthetized with sodium pentobarbital and the
gastrocnemius muscles were rapidly excised, weighed and frozen
under liquid nitrogen.
2.2. Chemicals
All chemicals were either obtained from Boehringer Mannheim
(Barcelona, Spain) or from Sigma (St. Louis, MO, USA). Human
recombinant TNF-K was kindly given by BASF/Knoll AG (Ludwigs-
hafen, Germany) and Dainippon Pharmaceuticals Co. (Osaka, Japan).
2.3. Cytokine administration
Animals were injected with an intravenous (tail vein) single dose of
TNF-K (100 Wg/kg body weight in 0.5 ml of 0.9% NaCl). Six hours
after the administration of the cytokine they were killed and muscle
samples were extracted.
2.4. RNA isolation and Northern blot analysis
Total RNA from gastrocnemius muscle was extracted using the acid
guanidinium isothiocyanate/phenol/chloroform method as described
[16]. RNA samples (20 Wg) were denatured, subjected to 1.2% agarose
gel electrophoresis containing 6.3% formaldehyde and transferred to
Hybond N membrane (Amersham). The RNA in gels and ¢lters was
visualized with ethidium bromide and photographed by UV transil-
lumination to ensure the integrity of RNA, to check the loading of
equivalent amounts of RNA and to con¢rm proper transfer. RNA
was transferred in 20Ustandard saline citrate (SSC; 0.15 M NaCl and
15 mM sodium citrate, pH 7.0). RNA was ¢xed to membrane by
Gene Linker (Bio-Rad).
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Prehybridization was done in a phosphate bu¡er (250 mM, pH 6.8)
containing 7% SDS, 1 mM EDTA and 1% BSA, during 1 h at 65‡C.
Membranes were hybridized in the same bu¡er with appropriate
probes (approx. 28 Bq/ng) at 65‡C for 18 h. Non-speci¢cally bound
probe was removed by successive washes in 2USSC+0.1% SDS (10
min at 65‡C) and 1USSC+0.1% SDS (10 min at 65‡C) and
0.1USSC+0.1% SDS (15 min at 65‡C, twice). Speci¢c hybridization
was then detected by autoradiography in Hyper¢lm-MP ¢lm (Amer-
sham) using intensi¢er screens for 1^4 days at 380‡C.
Radiolabeled probes were prepared by the random priming method
(Boehringer Mannheim). The probes used were the entire coding
frame for mouse UCP2 [1], a cDNA clone containing the entire cod-
ing from for mouse UCP3 (D.S. Fleury, C.F. Bouillard and D. Ric-
quier, GenBank accession number AF032902), and a 18S rat riboso-
mal probe used as hybridization/quanti¢cation standard. Blots were
quanti¢ed on a phosphoimager using the Phoretix 1D gel analysis
(Phoretix International, UK).
2.5. Statistical analysis
Statistical analysis of the data was performed by means of Student’s
t-test.
3. Results and discussion
Heat production in brown adipose tissue ^ an important
site of non-shivering thermogenesis in rodents [17] ^ has
long been associated with UCP1, a mitochondrial protein
carrier that stimulates heat production by uncoupling respira-
tion from ATP synthesis. The recent discovery of new mem-
bers of the mammalian mitochondrial uncoupling proteins
(UCP2 and UCP3) has resulted in a considerable amount of
information to elucidate the role of these proteins in patho-
physiological conditions.
The role of cytokines, TNF-K in particular, in thermoreg-
ulation and in regulating energetic e⁄ciency has been recog-
nized for a long time. Thus, it was demonstrated that, in the
young rat, a single intravenous TNF-K injection increased
brown adipose tissue thermogenesis, measured as mitochon-
drial GDP binding [13] ; a similar e¡ect was observed when
the cytokine was intracerebroventricularly injected [14]. It was
therefore the main aim of the present investigation to see if
TNF-K administration to rats resulted in any changes in
UCP2 or UCP3 gene expression.
Starvation results in an important increase in UCP2 gene
expression in skeletal muscle while it does not in£uence brown
adipose tissue [9]. Cold exposure also results in an increase in
UCP2 gene expression in skeletal muscle and brown adipose
tissue [9]. Interestingly, UCP2 levels are upregulated in white
adipose tissue in response to fat feeding, suggesting regulation
by diet [1]. The results obtained in our study show that TNF-
K treatment signi¢cantly increased UCP2 gene expression
(242%) in skeletal muscle (see Fig. 1). This is consistent with
previous observations in mice [15] showing an increase in
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Fig. 1. Upper panel: Northern blots of skeletal gastrocnemius muscle from control and TNF-treated rats. Expression of both UCP2 and UCP3
mRNA was detected after hybridization with cDNA probes (see Section 2). Autoradiographs were quanti¢ed by scanning densitometry and the
results are expressed as arbitrary units. Lower panel: Quanti¢cation of UCP2 (a) and UCP3 (b) mRNA in gastrocnemius from control and
TNF-treated rats. (a) n = 3 in each group. Signi¢cance of the di¡erences: P6 0.01. (b) n = 7 control group; n = 5 TNF-treated group. Signi¢-
cance: P6 0.01.
S. Busquets et al./FEBS Letters 440 (1998) 348^350 349
UCP2 mRNA in liver, muscle and adipose tissue following
either LPS or cytokine injection. It can therefore be suggested
that the cytokine e¡ects on energy expenditure could be par-
tially mediated by activation of UCP2 in skeletal muscle. It is
interesting to point out here that the induction of insulin
resistance by a high-fat diet is associated with increased
gene expression of TNF-K in white adipose tissue [18], thereby
suggesting that TNF overexpression in white adipose tissue
could be the trigger for the increased UCP2 expression in-
duced by a high-fat diet.
Interestingly, TNF treatment also increased UCP3 gene ex-
pression in skeletal muscle (113%), compared with the non-
treated animals (Fig. 1). This gene is abundantly expressed in
skeletal muscle and is highly tissue-speci¢c [6], its presence
having been detected also in brown adipose tissue of rodents
[3,4,7]. However, the regulation of its expression is still poorly
known. In muscle it is not a¡ected by cold acclimation [10]
although it is increased following thyroid hormone treatment
[19]; starvation increases UCP3 mRNA levels in skeletal
muscle while it decreases them in brown adipose tissue [3].
UCP3 expression is also decreased in the soleus muscle of
obese Zucker rats [10] suggesting that it could possibly have
a role in obesity. The fact that TNF-K treatment increases its
expression suggests that UCP3 may have a role in those
pathophysiological states where the cytokine is overproduced,
leading to a signi¢cant degree of energetic ine⁄ciency and
wasting such as infection or tumor growth (see [11] for re-
view).
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